Filing Details

Accession Number:
0001144204-14-008791
Form Type:
4
Zero Holdings:
No
Publication Time:
2014-02-13 20:25:39
Reporting Period:
2012-09-25
Filing Date:
2014-02-13
Accepted Time:
2014-02-13 20:25:39
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1335103 Protea Biosciences Group Inc. NONE Pharmaceutical Preparations (2834) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1529381 Ed Roberson 955 Hartman Run Road
Morgantown WV 26507
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2013-07-23 76,347 $0.50 235,456 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Convertible Note Disposition 2013-07-23 76,347 $38,174.00 76,347 $0.50
Common Stock Warrant Acquisiton 2013-07-23 57,260 $62,986.00 57,260 $1.10
Common Stock Stock Option Acquisiton 2010-04-23 100,000 $150,000.00 100,000 $1.50
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
110,000 2013-07-23 2013-07-23 No 4 C Direct
167,260 2013-07-23 2018-07-23 No 4 P Direct
267,260 2010-04-23 2020-04-23 No 4 P Direct
Footnotes
  1. On June 30, 2013, pursuant to the terms and conditions of a Conversion Agreement, dated June 7, 2013 (the "Conversion Agreement") Ed Roberson (the "Reporting Person") converted the outstanding principal and interest due pursuant to a convertible promissory note (the "Note") issued to the Reporting Person on September 25, 2012 (the "Issue Date") in an aggregate amount equal to $38,173.into 76,347 shares of common stock.
  2. Includes 167,600 shares of common stock owned of record by the Reporting Person and 67,856 shares of common stock owned of record by Morgan Keegan & Co., Inc. IRA c/o Ed Roberson (the "Roberson IRA").
  3. Represents the principal amount plus all accrued unpaid interest due under the Note.
  4. Includes options to purchase 100,000 shares of common stock issued to Mr. Roberson and warrants to purchase 110,000 shares of common stock owned of record by Mr. Roberson and the Roberson IRA.
  5. Represents shares vested as of February 10, 2014.